Form D · Biotechnology
Urolution Medical Inc.
Chaska, MN · CIK 0002034888
Offering snapshot reported Aug 27, 2024 · SEC filing
- Reported sold
- $200K Offering amount: $1.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 16, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2024 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-522477
Source: Form D, filed Aug 27, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Youshi Mi | Director, Executive |
| Shaolong Qu | Executive |
| Jon St. Germain | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3925 Carver Cir.
Chaska, MN, 55318
Chaska, MN, 55318